Tumblr Fave Likes Y...
Health Care: Drugs
Oncothyreon Inc. (ONTY: NASDAQ)
$2.00 0.00 | 0.00%
05/21/13 - 09:30 AM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -3.42M | -42.66M | -15.62M | -17.22M |
| Operating Gains/Losses | 0.00 | 0.00 | 6.00K | 7.00K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 11.00K | 286.00K | -547.00K | 1.82M |
| (Increase) Decrease in Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | 674.00K | -165.00K | -2.00K | 147.00K |
| (Decrease) Increase In Other Current Liabilities | -251.00K | 926.00K | -238.00K | -1.80M |
| (Increase) Decrease In Other Working Capital | -390.00K | 390.00K | 135.00K | 0.00 |
| Other Non-Cash Items | -24.26M | 19.64M | -1.55M | 7.51M |
| Net Cash From Continuing Operations | -27.34M | -21.00M | -17.70M | -9.11M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -27.34M | -21.00M | -17.70M | -9.11M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 20.21M | 1.88M |
| Purchases of Property, Plant & Equipment | -752.00K | -142.00K | -324.00K | -1.43M |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | 0.00 | 0.00 | -29.33M | -16.13M |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 34.00K |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -7.44M | -31.56M | -9.44M | -15.64M |
| Issuance of Debt | 0.00 | 4.80M | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 50.48M | 54.19M | 13.69M | 24.56M |
| Repayment of Long-Term Debt | -5.04M | -151.00K | 0.00 | 0.00 |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | -189.00K | 0.00 | 0.00 |
| Net Cash From Financing Activities | 45.43M | 58.65M | 13.69M | 24.56M |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | 10.66M | 6.10M | -13.46M | -192.00K |
Portfolios with ONTY
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- Contributor7 Cancer Drug Stocks to Kno...
- ContributorBreakout Stocks Of The Week...
Latest ONTY Headlines from TheStreet
- 4 Biotech Stocks Under $10 Making Big Moves 04.09.13 | 02:04 pm
- 5 Stocks Under $10 Set to Soar 02.28.13 | 01:02 pm
- 3 Pharma Stocks Leaping on Unusual Volume 01.10.13 | 02:01 pm
- Biotech Stock Mailbag: Amicus, Amarin, Oncothyreon 12.21.12 | 07:12 am
- Stocks Slip as Pessimism Clouds Fiscal-Cliff Talks 12.19.12 | 02:12 pm
- Oncothyreon: A Failed Drug Autopsy Performed By A Short Seller 12.19.12 | 10:12 am
- Stock Futures Rise Ahead of Housing Data 12.19.12 | 07:12 am
- Merck KGaA, Oncothyreon Lung Cancer Drug Fails Late-Stage Study 12.19.12 | 06:12 am
- 4 More Stocks Leaping on Unusual Volume 12.11.12 | 03:12 pm
- First 90 Days of 2013 Are Live or Die For These Biotech Stocks 11.19.12 | 09:11 am
Press Releases for ONTY
- Oncothyreon Announces Data For L-BLP25 And PX-866 To Be Presented At American Society Of Clinical Oncology Meeting - PR Newswire 05.16.13 | 06:05 am
- Oncothyreon Announces First Quarter 2013 Financial Results Conference Call - PR Newswire 05.02.13 | 08:05 am
- Oncothyreon To Present At Future Leaders In The Biotech Industry Conference - PR Newswire 03.29.13 | 08:03 am
- Oncothyreon Announces Full Year And Fourth Quarter 2012 Financial Results Conference Call - PR Newswire 03.07.13 | 08:03 am
- Oncothyreon To Present At Cowen And Company 33rd Annual Health Care Conference - PR Newswire 02.27.13 | 08:02 am
- Oncothyreon Announces That L-BLP25 (Stimuvax®) Did Not Meet Primary Endpoint Of Improvement In Overall Survival In Pivotal Phase 3 Trial In Patients With Non-Small Cell Lung Cancer - PR Newswire 12.19.12 | 06:12 am
- Oncothyreon Announces Presentations At Upcoming Investment Conferences In November 2012 - PR Newswire 11.07.12 | 08:11 am
- Oncothyreon Announces Third Quarter 2012 Financial Results Conference Call - PR Newswire 10.31.12 | 08:10 am
- Oncothyreon Expands Phase 2 Trial Of Its PI-3 Kinase Inhibitor PX-866 In Patients With Prostate Cancer - PR Newswire 09.05.12 | 08:09 am
- Oncothyreon Announces Presentations At Upcoming Investment Conferences In September 2012 - PR Newswire 08.29.12 | 08:08 am
Partner Headlines for ONTY
- Stock Watch Thursday, 20 December - Seeking Alpha 12.20.12 | 09:12 am
- Long term spread targets Oncothyreon - NASDAQ 08.30.12 | 04:08 pm
- Reassessing & Continuing To Monitor Portfolios For Success - Seeking Alpha 07.30.12 | 09:07 am
- Oncothyreon Announces Presentation of PX-866 Clinical Data at American Association of Clinical Oncology Annual Meeting - Benzinga 06.02.12 | 06:06 pm
- Must Know Equity Upgrades and Downgrades Wednesday - Wall St. Cheat Sheet 05.23.12 | 03:05 am
- Interesting Reaction To Oncothyreon's Share Offering - Seeking Alpha 03.30.12 | 08:03 am
- Cytori Is A Compelling Short Sale Opportunity - Seeking Alpha 03.19.12 | 09:03 am
- Oncothyreon And Lpath: Shares Collapsed, Primed For A Rebound? - Seeking Alpha 03.09.12 | 09:03 am
- Immunocellular Again Pushing To $2 - Seeking Alpha 02.15.12 | 09:02 am
- Stocks To Watch Week Of Feb. 6 - Seeking Alpha 02.06.12 | 08:02 am
